Catálogo de productos [{"id":"526","name":"Lytgobi","price":12903.03,"sku":"Lytgobi (futibatinib)","brand":"Taiho Pharmaceuticals","position":1,"category":"Medicines\/Oncology\/Bile Duct Cancer"},{"id":"445","name":"Truseltiq","price":1,"sku":"Truseltiq (infigratinib)","brand":"QED Therapeutics","position":2,"category":"Medicines\/Oncology\/Bile Duct Cancer"},{"id":"391","name":"Pemazyre","price":14836.16,"sku":"Pemazyre (pemigatinib)","brand":"Incyte Corporation","position":3,"category":"Medicines\/Oncology\/Bile Duct Cancer"},{"id":"309","name":"Tibsovo","price":27631.8,"sku":"Tibsovo (ivosidenib)","brand":"Agios Pharmaceuticals, Inc.","position":4,"category":"Medicines\/Oncology\/Bile Duct Cancer"}]

Opciones de acceso al cáncer de vías biliares

  1. Tibsovo
    Tibsovo (ivosidenib)
    Leucemia, cáncer de vías biliares
    €27,631.80
  2. Pemazyre
    Pemazyre (pemigatinib)
    Cáncer del conducto biliar
    €14,836.16
  3. Truseltiq
    Truseltiq (infigratinib)
    Cáncer del conducto biliar
    Precio disponible a petición
  4. Lytgobi
    Lytgobi (futibatinib)
    Cáncer del conducto biliar
    €12,903.03
Ver como Cuadrícula Lista

4 artículos

Establezca la dirección de descenso
EE.UU. 0